This review summarizes how changes in ACE2’s expression, isoforms, and interactions with other proteins in the brain due to SARS-CoV-2 infection may influence the development of neurodegenerative processes that are akin to Alzheimer’s disease. This evidence concerns the gene ACE2 and early-onset autosomal dominant Alzheimer disease.